Pharmaceutical
ChemLinkedMarketChemicalFoodCosmeticPharmaceuticalJapanAgrochemicalSustainability
News
Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
INDUSTRY
Marketing Approval Innovative Drug Generic Drug New Drug
Monthly Report: New Drug Approvals in China | June 2021 In June 2021, China NMPA granted 21 new drug approvals.
Jul 14, 2021
INDUSTRY
Marketing Approval Cell Therapy Gene Therapy
China Approves First Domestic CAR-T Therapy Fosun Kite's Axicabtagene Ciloleucel recently received marketing authorization by NMPA, becoming the first CAR-T therapy approved in China. The Chinese CAR-T industry is thus eyeing a promising future, but the road to market success is challenging.
Jul 12, 2021
POLICY
Volume-based Procurement
A Record Number of Foreign Companies Win Bidding for China's 5th VBP of Drugs 251 products from 148 companies won the bidding on June 23 in Shanghai for the latest and fifth round of China’s national centralized drug procurement. The bidding saw some record numbers. One of them is the unprecedented number of 10 international pharma companies successfully earning places in the procurement program.
Jun 30, 2021
REGULATION
Law & Regulation
Monthly Recap: China Pharmaceutical Regulatory Updates | May 2021 The monthly recap is intended to bring you recent major laws and regulations issued by China drug regulators.
Jun 18, 2021
INDUSTRY
Marketing Approval Priority Review Drug Registration New Drug
Monthly Report: New Drug Approvals in China | May 2021 In May 2021, China NMPA granted approvals to a total of nine innovative new drugs, improved new drugs, imported original drugs and first generics.
Jun 15, 2021
POLICY
OTC Drug E-commerce
China to Pilot Cross-Border E-Commerce Retail Import of Drugs China recently approved Henan Province’s cross-border e-commerce pilot program for importing drugs and medical devices, starting with 13 OTC medicines licensed in China. Thanks to the pilot program, more overseas drugs, including anti-cancer and targeted therapy drugs, stand a chance of accessing the Chinese market. This article focuses on drug import as part of the pilot program.
Jun 04, 2021
POLICY
Volume-based Procurement
Data Analysis: What "4+7" Procurement Has Brought to China Drug Market The “4+7” procurement program opens a gate to a larger market for some drug products. But larger sales volume does not necessarily mean higher sales revenue.
May 31, 2021
POLICY
NRDL Health Insurance
China Promotes Distribution of Medicare-covered Drugs Through Dual Channel China permits qualified drug stores to sell prescription drugs included in the National Reimbursement Drug List. At these drug stores, people can enjoy the same medical care payment coverage with hospitals. The policy intends to add another sales channel for the drugs outside hospitals, especially for the newly listed drugs through centralized procurement.
May 24, 2021
INDUSTRY
Marketing Approval Priority Review Drug Registration New Drug
Monthly Report: New Drug Approvals in China | April 2021 In Apr. 2021, China NMPA approved a total of 12 new drugs. Eight of them are therapeutic biological products and the other four are chemical drugs.
May 14, 2021
REGULATION
Law & Regulation Guideline
Monthly Recap: China Pharmaceutical Regulatory Updates | April 2021 In Apr. 2021, China National Medical Products Administration (NMPA) and its subordinate body Center for Drug Evaluations (CDE) published a series of regulations on medical products, including pediatric medicine and biosimilars.
May 12, 2021
Pre 1... 2223242526 ...27 Next
Most Popular